Resolute Holdings Management, Inc.
RHLD NYSE Finance Services Financials FY2024βFY2025
What Resolute Holdings Management, Inc. does
No business description yet.
- Legal name
- Resolute Holdings Management, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 12, 2026
- Accession Β· CIK
- 0001104659-26-027050
0002039497
Revenue and margins
Resolute Holdings Management, Inc. had $462M of revenue in fiscal 2025, up 9.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $189M in fiscal 2025, 41.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Resolute Holdings Management, Inc. returned $4.1M to shareholders in fiscal 2025, 2% of free cash flow. The diluted share count fell 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Resolute Holdings Management, Inc. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $71.6M | $206M |
| Debt incl. finance leases | $196M | $184M |
| Net debt / EBITDA | 0.9x | β0.1x |
| Debt / equity | β | 28.3x |
| Interest coverage | 6.3x | 10.9x |
| Current ratio | 3.3x | 3.8x |
| Quick ratio | 2.4x | 3.3x |
| Total assets | $202M | $333M |
| Total liabilities | $238M | $255M |
| Shareholders' equity | β$0.8M | $6.5M |
| Net debt (β = net cash) | $124M | β$21.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | β | β |
| Cash from operations is positive | β | β |
| Return on assets rose | β | β |
| Cash from operations exceeds net income | β | β |
| Debt fell relative to assets | β | β |
| Current ratio rose | β | β |
| Share count didn't rise | β | β |
| Gross margin rose | β | β |
| Revenue rose relative to assets | β | β |
| F-score | β / 3 | 6 / 9 |
| Accruals ratio | β76.5% | β75.6% |
| Altman Z'' | 7.96 | 7.17 |
2 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $421M | $462M |
| Gross profit | $219M | $260M |
| Research and development | $7.4M | $6.6M |
| Operating income | $127M | $143M |
| Interest expense | $20.2M | $13.2M |
| Pretax income | $110M | $135M |
| Income tax | β$0.0M | $0.9M |
| Net income | β$2.3M | β$5.9M |
| Diluted EPS | β$0.27 | β$0.69 |
| Diluted shares | 0.01B | 0.01B |
| Cash flow | ||
| Cash from operations | $152M | $196M |
| Capital expenditure | $7.4M | $6.9M |
| Free cash flow | $145M | $189M |
| Depreciation and amortization | $9.2M | $8.5M |
| Stock-based compensation | $19.9M | $26.8M |
| Share buybacks | β | $4.1M |
| Dividends and buybacks | β | $4.1M |
| Balance sheet | ||
| Cash and short-term investments | $71.6M | $206M |
| Total debt | $196M | $184M |
| Current assets | $167M | $298M |
| Current liabilities | $50.1M | $77.6M |
| Inventory | $44.8M | $44.2M |
| Property and equipment, net | $23.4M | $21.6M |
| Intangible assets | β | $1.9M |
| Total assets | $202M | $333M |
| Total liabilities | $238M | $255M |
| Shareholders' equity | β$0.8M | $6.5M |
| Margins | ||
| Gross margin | 52.1% | 56.3% |
| Operating margin | 30.1% | 31.0% |
| EBITDA margin | 32.3% | 32.8% |
| Net margin | β0.6% | β1.3% |
| FCF margin | 34.4% | 41.0% |
| Returns | ||
| Return on capital | 102.7% | β |
| Return on capital employed | 83.4% | 56.2% |
| Return on equity | β | β207.5% |
| Return on assets | β1.2% | β2.2% |
| Return on tangible equity | β | β128.8% |
| Growth | ||
| Revenue growth | β | 9.9% |
| FCF growth | β | 30.8% |
| Share count change | β | β0.0% |
| Financial health | ||
| Net debt / EBITDA | 0.9x | β0.1x |
| Debt / equity | β | 28.3x |
| Interest coverage | 6.3x | 10.9x |
| Current ratio | 3.3x | 3.8x |
| Quick ratio | 2.4x | 3.3x |
| Capital allocation | ||
| Capex / revenue | 1.8% | 1.5% |
| Stock comp / revenue | 4.7% | 5.8% |
| Payouts / FCF | β | 2.2% |
| Quality scores | ||
| Piotroski F-score | β | 6.0 |
| Altman Z'' | 8.0 | 7.2 |
| Accruals ratio | β76.5% | β75.6% |
Source: SEC EDGAR XBRL filings (CIK 0002039497). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.